title: CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis.
abstract: BACKGROUND
  There is evidence for a relationship between low levels of 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF) and suicidal behavior in mood disorder. A relationship between CSF homovanillic acid (HVA) and suicidal behavior has not been completely established. Studies done in patients with schizophrenia spectrum psychosis suffer from small numbers, short periods of follow-up and the results are contradictory. The objective of this study was to investigate the relationship between levels of CSF 5-HIAA, CSF HVA and suicidal behavior in patients with schizophrenia spectrum psychosis.
  
  
  METHODS
  Three hundred eighty five patients with schizophrenia spectrum psychosis admitted to the Karolinska University Hospital between 1973 and 1987 were lumbar punctured in standardized manner. Patients were followed until 2006 for a median of 26 years. Information about prior suicide attempt was retrieved from medical records and causes of death were obtained from the Causes of Death Register at the National Board of Health and Welfare.
  
  
  RESULTS
  At the end of the follow-up 26 patients (6.8%) had died by suicide. Male gender (OR=3.5) and attempted suicide (OR=12.4) were risk factor for suicide when combined. There were no significant correlations between levels of CSF 5-HIAA, CSF HVA, HVA/5-HIAA ratio and attempted, violent or non-violent suicide.
  
  
  CONCLUSIONS
  Male schizophrenia spectrum psychosis patients with prior suicide attempt are at high risk for suicide. No correlation between CSF monoamine metabolites levels and suicidal behavior was found. Suicidal behavior in schizophrenia spectrum psychosis may not, in contrast to mood disorders, be predicted by levels of CSF 5-HIAA and HVA.
authors.affiliation: Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden. andreas.carlborg@sll.se
authors.forename: Andreas
authors.initials: A
authors.lastname: Carlborg
authors.forename: Jussi
authors.initials: J
authors.lastname: Jokinen
authors.forename: Anna-Lena
authors.initials: AL
authors.lastname: Nordström
authors.forename: Erik G
authors.initials: EG
authors.lastname: Jönsson
authors.forename: Peter
authors.initials: P
authors.lastname: Nordström
mesh_terms: D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008297:Male; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000134:cerebrospinal fluid* / Q000150:complications; D012189:Retrospective Studies; D012307:Risk Factors; D012559:Schizophrenia / Q000134:cerebrospinal fluid* / Q000150:complications; D012565:Schizophrenic Psychology; D012737:Sex Factors; D013406:Suicide, Attempted / Q000523:psychology*; D055815:Young Adult
chemical_list: D006897:Hydroxyindoleacetic Acid